Correlation Between CSL and APELLIS PHARMACTDL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSL and APELLIS PHARMACTDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and APELLIS PHARMACTDL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL LTD SPONADR and APELLIS PHARMACTDL 0001, you can compare the effects of market volatilities on CSL and APELLIS PHARMACTDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of APELLIS PHARMACTDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and APELLIS PHARMACTDL.

Diversification Opportunities for CSL and APELLIS PHARMACTDL

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between CSL and APELLIS is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding CSL LTD SPONADR and APELLIS PHARMACTDL 0001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on APELLIS PHARMACTDL 0001 and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL LTD SPONADR are associated (or correlated) with APELLIS PHARMACTDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of APELLIS PHARMACTDL 0001 has no effect on the direction of CSL i.e., CSL and APELLIS PHARMACTDL go up and down completely randomly.

Pair Corralation between CSL and APELLIS PHARMACTDL

Assuming the 90 days trading horizon CSL is expected to generate 73.87 times less return on investment than APELLIS PHARMACTDL. But when comparing it to its historical volatility, CSL LTD SPONADR is 2.58 times less risky than APELLIS PHARMACTDL. It trades about 0.01 of its potential returns per unit of risk. APELLIS PHARMACTDL 0001 is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  2,676  in APELLIS PHARMACTDL 0001 on September 21, 2024 and sell it today you would earn a total of  452.00  from holding APELLIS PHARMACTDL 0001 or generate 16.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CSL LTD SPONADR  vs.  APELLIS PHARMACTDL 0001

 Performance 
       Timeline  
CSL LTD SPONADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSL LTD SPONADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking indicators, CSL is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
APELLIS PHARMACTDL 0001 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in APELLIS PHARMACTDL 0001 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, APELLIS PHARMACTDL reported solid returns over the last few months and may actually be approaching a breakup point.

CSL and APELLIS PHARMACTDL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSL and APELLIS PHARMACTDL

The main advantage of trading using opposite CSL and APELLIS PHARMACTDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, APELLIS PHARMACTDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in APELLIS PHARMACTDL will offset losses from the drop in APELLIS PHARMACTDL's long position.
The idea behind CSL LTD SPONADR and APELLIS PHARMACTDL 0001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon